Game-Changing Biomarker Test Detects Early-Stage Alzheimer's
2025-02-15
Researchers at the University of Pittsburgh have developed a biomarker test that can detect minute amounts of clumped tau protein in the brain and cerebrospinal fluid, a hallmark of Alzheimer's disease. This breakthrough allows for early detection—up to a decade before noticeable symptoms or brain scan abnormalities—opening the door for potentially life-altering interventions. The test identifies specific modifications within the tau protein, providing an early warning system for this currently incurable disease. This significant advance builds on recent Alzheimer's research breakthroughs, including the identification of subtypes and novel therapeutic approaches.